January 20, 2011 — Boca Raton, FL – The Institute for the Commercialization of Public Research (the Institute) announced today that two Phase I projects and eleven Phase II projects in ten cities across Florida will share nearly $3 million in grant funding through the Florida Research Commercialization Matching Grant Program (FRCMGP) for projects ranging from the life sciences to advanced materials to energy.  

(more…)

JACKSONVILLE, FL – GXHC, a Jacksonville-based medical device development manager and portfolio investor, says it is raising $50 million to fund its medical device portfolio and additional proprietary US device companies. (more…)

SUNRISE, FL – Bioheart, Inc. (OTCBB:BHRT) has entered into an agreement with AnC Bio Holdings Inc., a South Korean biomedical company, and one of its U.S. agents for a $4 million equity investment. Bioheart has designated proceeds from the investment to advance the current clinical evaluation of its cell therapies for treating heart failure and related cardiac diseases. (more…)

ATLANTA, GA - Birmingham, Ala.-based Atherotech, a developer of a novel cholesterol test that was spun out of the University of Alabama, has been acquired by the New York-based investment firm Behrman Capital. Terms of the deal weren’t disclosed. (more…)

MARIETTA, GA – Amendia Inc., a company that works with surgeon partners to develop minimally invasive, implantable medical devices, has raised $450,000 of a round targeted at $5 million, according to a regulatory filing. (more…)

ATLANTA – Gliknik Inc., a biopharmaceutical company developing treatments for cancer and autoimmune diseases, has raised $849,000 of a mixed securities offering targeted at $3.9 million, according to a regulatory filing. Six investors contributed thus far. (more…)